StonvexLoading…
StonvexStonvexStonvexCore line items from STZ's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2026 2026-02-28 | Q4 2025 2025-11-30 | Q3 2025 2025-08-31 | Q2 2025 2025-05-31 |
|---|---|---|---|---|
Revenue | $9.14B | $7.22B | $5.00B | $2.52B |
Operating Income | $2.72B | $2.28B | $1.59B | $713.80M |
Net Income | $1.69B | $1.48B | $982.10M | $516.10M |
EPS (Diluted) | Not available | Not available | Not available | Not available |
Total Assets | $21.90B | $21.68B | $21.42B | $22.26B |
Total Liabilities | $13.51B | $13.68B | $13.63B | $14.73B |
Cash & Equivalents | $102.40M | $152.40M | $72.00M | $73.90M |
Free Cash Flow OCF − CapEx | $1.79B | $1.45B | $1.08B | $444.40M |
Shares Outstanding | Not available | Not available | Not available | Not available |